NEW YORK, July 4, 2025 /PRNewswire/ -- According to a new comprehensive report from The Insight Partners, the global digital twin market is observing significant growth owing to the increasing adoption of IoT devices, large-scale digital transformation, and Industry 4.O adoption across enterprises and surging emphasis on predictive maintenance. The digital twin market was valued at US$10.305 billion in 2023 and is projected to reach US$140.93 billion by 2031; it is expected to register a CAGR of 38.7% during 2023–2031. The increasing adoption of IoT devices, large-scale digital transformation, and industry 4.O adoption across enterprises and surging emphasis on predictive maintenance are a

Axos Financial ("Axos") celebrates twenty-five years of successful evolution from a consumer-focused digital bank into a leading full-spectrum financial services firm. Today, Axos serves consumers, small businesses, and commercial and institutional clients nationwide across with a comprehensive range of deposit, lending, and securities services, all delivered with a focus on technological excellence. Over its 25-year history Axos Financial has been widely recognized for its innovation in digital banking and strong financial performance. Axos's founders selected July 4th as its launch date to symbolize the freedom that a financial services firm focused on digital delivery could provide to

BEIJING, July 4, 2025 /PRNewswire/ -- Autozi Internet Technology (Global) Ltd. (NASDAQ:AZI) ("Autozi" or the "Company"), an automotive products and services company in China, today announced that it has received a notification letter dated July 2, 2025 (the "Notice") from the staff of the Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq"), indicating that for the last 30 consecutive business days, the closing bid price of the Company's American depositary shares (the "ADSs") was below the minimum bid price of US$1.00 per share requirement set forth in Nasdaq Listing Rule 5450(a)(1). The Notice has no current effect on the listing or trading of the Company's ADSs on N

DUBAI, UAE, July 4, 2025 /PRNewswire/ -- Bybit, the world's second-largest cryptocurrency exchange by trading volume, has released a new Bybit TradFi x Crypto Report looking beyond PEs in evaluating the growth potential of Coinbase Global Inc. (NASDAQ:COIN). While the U.S.-based cryptocurrency exchange trades at premium valuations, positive regulatory momentum, institutional acceptance, and Coinbase's strategic product launches position it for continued top-line expansion. The latest report follows a recent analysis tracking Circle's ascend, the new stablecoin darling on Wall

Citigroup reiterated coverage of Crown with a rating of Buy and set a new price target of $129.00 from $119.00 previously

Citigroup reiterated coverage of DuPont with a rating of Buy and set a new price target of $85.00 from $75.00 previously

BNP Paribas Exane upgraded UPS from Underperform to Neutral and set a new price target of $100.00

Janney initiated coverage of Primoris Services with a rating of Buy

4 - JUPITER NEUROSCIENCES, INC. (0001679628) (Issuer)

4 - HOUSTON AMERICAN ENERGY CORP (0001156041) (Issuer)

4 - Asana, Inc. (0001477720) (Issuer)

4 - JUPITER NEUROSCIENCES, INC. (0001679628) (Issuer)

4 - AEHR TEST SYSTEMS (0001040470) (Issuer)

4 - GRAN TIERRA ENERGY INC. (0001273441) (Issuer)

4 - GRAN TIERRA ENERGY INC. (0001273441) (Issuer)

4 - GRAN TIERRA ENERGY INC. (0001273441) (Issuer)

SCHEDULE 13D/A - Pelthos Therapeutics Inc. (0001919246) (Subject)

SCHEDULE 13D/A - Principal Real Estate Income Fund (0001557523) (Subject)

SCHEDULE 13D/A - GoodRx Holdings, Inc. (0001809519) (Subject)

SCHEDULE 13D - CIMPRESS plc (0001262976) (Subject)

For Immediate Release: March 28, 2025 Today, the U.S. Food and Drug Administration approved Qfitlia (fitusiran) for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adult and pediatric patients 12 years of age and older with hemophilia A or hemophilia B, with or without factor VIII or IX inhibitors (neutralizing antibodies).“Today’s approval of Qfitlia is significant for patients wi

For Immediate Release: March 11, 2025 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:Today, the FDA published a General Correspondence Letter issued to Mid-Link Technology Testing Co., Ltd. The FDA is vigilant in ensuring data submitted to the FDA can be relied upon to assess the effectiveness, safety, or risk of a device. The FDA has noted an incr

For Immediate Release: February 28, 2025 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:On Thursday, the FDA approved Odactra to include use in individuals 5 through 11 years of age to treat house dust mite induced nasal inflammation (allergic rhinitis), with or without eye inflammation (conjunctivitis). Odactra is an allergen extract immunotherapy

For Immediate Release: February 21, 2025 Today, the U.S. Food and Drug Administration approved Ctexli (chenodiol) for the treatment of cerebrotendinous xanthomatosis (CTX) in adults. Ctexli is the first FDA-approved drug to treat CTX, a very rare lipid storage disease.“The FDA is dedicated to supporting new drug development for rare diseases including very rare metabolic diseases like cerebrotendinous xanthomato

ISS states, "[T]he [current] board appears to be working to pay SVA shareholders their fair share of dividends, and to resume trading of the company's shares, which are the two most pressing issues currently facing SVA shareholders." SINOVAC's Board of Directors encourages shareholders to follow recommendations by ISS and Glass Lewis and VOTE the WHITE proxy card "AGAINST" the misguided proposals to remove the SINOVAC Board and appoint the Reconstituted Imposter Former Board Slate Special Meeting of SINOVAC shareholders to be held on July 8, 2025 To learn more, visit: VoteSinovac.com The Board of Directors of SINOVAC Biotech Ltd. (NASDAQ:SVA) ("SINOVAC" or the "Company"), a leading

NORWALK, Conn., July 3, 2025 /PRNewswire/ -- Emeren Group Ltd ("Emeren" or the "Company") (www.emeren.com) (NYSE:SOL), a leading global solar project developer, owner, and operator, today announced a leadership transition within its North America operations. Mr. Cameron "Mac" Moore, Executive Vice President - North America, has departed the Company, and Mr. M. Jahangir Alam has been appointed as his successor, effective immediately. About M. Jahangir Alam M. Jahangir Alam is a seasoned leader in the North American renewable energy industry, with nearly three decades of experie

TORONTO, July 03, 2025 (GLOBE NEWSWIRE) -- McEwen Mining Inc. (NYSE:MUX) (TSX:MUX) ("MUX" or the "Company") announces the results of the MUX Annual Meeting of Shareholders held on June 19, 2025. Following shareholder approval, the Company has filed the Articles of Amendment with the Secretary of State to effect the approved name change on July 7, 2025. The Company will begin trading on the NYSE under its new name, McEwen Inc., on July 7, 2025, and on the TSX shortly thereafter. There will be no change in the Company's CUSIP or stock symbol. Voting Overview: Shares Voted: 27,942,541 (~51.81% of 53,934,510 outstanding shares entitled to vote)Board Elected: 11 DirectorsExecutive Compensatio

IRVINE, CA, and HERSTAL, BELGIUM – July 3, 2025 (GlobeNewswire) – MDxHealth SA (NASDAQ:MDXH) (the "Company" or "mdxhealth"), a leading precision diagnostics company, today announced the appointment of Michael Holder to its Board of Directors as the Chair of the Audit Committee. Mr. Holder will take the seat of Regine Slagmulder, whose term completed in May. Mr. Holder is a highly accomplished executive with over 30 years of diverse experience, including nine board, four CEO, and five CFO roles across public and private biotech, medtech, health tech, pharma, and wellness companies. His expertise encompasses corporate strategy, M&A, corporate governance, and sales productivity. He's led a $25

GUADALAJARA, Mexico, July 03, 2025 (GLOBE NEWSWIRE) -- Grupo Aeroportuario del Pacífico, S.A.B. de C.V., (NYSE:PAC, BMV:GAP) ("the Company" or "GAP") announces preliminary terminal passenger traffic figures for June 2025, compared with June 2024. During this period, the total number of terminal passengers at GAP's 12 Mexican airports increased by 0.7%, compared to June 2024. Los Cabos airport presented an increase in passenger traffic of 1.7%, while Tijuana, Guadalajara, and Puerto Vallarta airports decreased 2.3%, 1.1%, and 0.1% respectively, compared to June 2024. On the other hand, Montego Bay presented a decrease in passenger traffic of 1.9%, compared to June 2024. Domestic Termi

PANAMA CITY, July 03, 2025 (GLOBE NEWSWIRE) -- Copa Holdings, S.A. (NYSE:CPA) announces the following events: Earnings Release – Second Quarter 2025Date:August 6, 2025Time:After US market closeThis release will be available on our website: https://ir.copaair.com/financial-information/quarterly-results  Earnings Conference Call and Webcast Date:August 7, 2025Time:11:00 AM US ET (10:00 AM Local Time)Join by phone: https://register-conf.media-server.com/register/BI3fd974d31bd0466892173693289b7b8bWebcast (listen-only):https://ir.copaair.com/events-and-presentations  We encourage our listeners to join the conference via webcast. To ensure a smooth experience, please access the website and compl

DALLAS, July 03, 2025 (GLOBE NEWSWIRE) -- Texas Capital Bancshares, Inc. (NASDAQ:TCBI), the parent company of Texas Capital Bank, today announced that it expects to issue financial results for the second quarter of 2025 before market on Thursday, July 17, 2025. Executive management will host a conference call and webcast to discuss second quarter 2025 operating results on Thursday, July 17, 2025, at 9:00 a.m. EDT. Participants may pre-register for the call by visiting https://www.netroadshow.com/events/login?show=3539d7ee&confId=85196 and will receive a unique PIN number to be used when dialing in for the call for immediate access. Alternatively, participants may call 833.470.1428 an

THE WOODLANDS, Texas, July 03, 2025 (GLOBE NEWSWIRE) -- LGI Homes, Inc. (NASDAQ:LGIH) today announced it closed 457 homes in June 2025 and closed 1,323 homes in the second quarter of 2025. As of June 30, 2025, the Company had 146 active selling communities. The Company plans to release financial results for the second quarter ended June 30, 2025 before the market opens on Tuesday, August 5, 2025. The Company will hold a conference call at 12:30 p.m. Eastern Time on the same day to discuss the results. A link to the live audio webcast will be provided through the Investor Relations page of the Company's website at www.investor.lgihomes.com under the Events and Presentations section. An

SC 13D/A - ALLIANCEBERNSTEIN HOLDING L.P. (0000825313) (Subject)

SC 13D/A - CVR ENERGY INC (0001376139) (Subject)

SC 13D/A - INCOME OPPORTUNITY REALTY INVESTORS INC /TX/ (0000949961) (Subject)

SC 13D/A - Arcus Biosciences, Inc. (0001724521) (Subject)

Recently, on July 4, 2024, a significant insider purchase was recorded at Allied Gaming & Entertainment Inc. as Large owner Choi Roy bought $456,750 worth of shares (360,000 units at $1.27), increasing direct ownership by 14% to 2,871,822 units (SEC Form 4). This purchase is notable for the size of the transaction and the percentage increase in direct ownership, indicating a strong belief in the company's future prospects. Insider purchases are generally viewed positively by investors as they signal confidence from those with intimate knowledge of the company's operations. Examining other recent insider transactions at Allied Gaming & Entertainment Inc., we notice a few patterns worth explo

Recently, on June 25, 2024, Director Romano Kelly A bought $100,051 worth of shares in Athira Pharma Inc. This transaction involved acquiring 42,400 units at $2.36 per share, resulting in a significant increase in direct ownership by 111% to 80,715 units. The purchase was disclosed in the SEC Form 4 filing. Insider buying is often considered a bullish signal as insiders may have insights into the company's future performance. It's essential to analyze this insider purchase in conjunction with previous insider transactions to identify any patterns or trends. Taking into account the information from the SEC filings, several other insiders at Athira Pharma Inc. have also been active in the sto

Recently, on June 26, 2024, Director Juda Scott bought $36,350 worth of shares (5,000 units at $7.27) (SEC Form 4) in INmune Bio Inc. This insider purchase is significant as it indicates confidence from someone within the company towards its future growth prospects. It's interesting to note that this purchase by Juda Scott follows a series of transactions by other insiders in the company. For example, Moss David J bought $149,993 worth of shares (18,028 units at $8.32) on April 24, 2024, increasing direct ownership by 1% to 1,268,179 units. This demonstrates a consistent trend of insider buying within the organization. Looking back at previous transactions, on May 16, 2024, several key ins

Monopar Therapeutics Inc. has recently seen notable insider activity, with Chief Operating Officer Cittadine Andrew purchasing $25,574 worth of shares on June 21st, 2024. This purchase, comprising 32,508 units at $0.79, increased Cittadine's direct ownership by 21% to 186,132 units as reported in the SEC Form 4. When analyzing this transaction alongside other recent insider activities within the company, interesting patterns and trends start to emerge. Looking back, Cittadine Andrew has been consistently adding to his position in Monopar Therapeutics Inc. over the past few months, showcasing a strong conviction in the company's future prospects. On May 31st, Cittadine Andrew made a substan